Follow
Feng Xie
Feng Xie
Professor, Department of Clinical Epidemiology and Biostatistics
Verified email at mcmaster.ca - Homepage
Title
Cited by
Cited by
Year
A TTO-derived value set of the EQ-5D-5L for Canada
JJACEQDLVSG Xie F, Pullenayegum EM, Gaebel K, Bansback N, Bryan S, Ohinmaa A ...
Medical Care, 54 (1), 98, 2016
355*2016
United States valuation of EQ-5D-5L health states using an international protocol
AS Pickard, EH Law, R Jiang, E Pullenayegum, JW Shaw, F Xie, M Oppe, ...
Value in health 22 (8), 931-941, 2019
2342019
A human type 5 adenovirus–based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity
F Smaill, M Jeyanathan, M Smieja, MF Medina, N Thanthrige-Don, ...
Science translational medicine 5 (205), 205ra134-205ra134, 2013
2252013
Effect of patient-centered transitional care services on clinical outcomes in patients hospitalized for heart failure: the PACT-HF randomized clinical trial
HGC Van Spall, SF Lee, F Xie, UE Oz, R Perez, PR Mitoff, M Maingi, ...
Jama 321 (8), 753-761, 2019
2242019
Economic and humanistic burden of osteoarthritis: a systematic review of large sample studies
F Xie, B Kovic, X Jin, X He, M Wang, C Silvestre
Pharmacoeconomics 34, 1087-1100, 2016
2112016
Instrument-defined estimates of the minimally important difference for EQ-5D-5L index scores
NS McClure, F Al Sayah, F Xie, N Luo, JA Johnson
Value in Health 20 (4), 644-650, 2017
2102017
GRADE guidelines: 20. Assessing the certainty of evidence in the importance of outcomes or values and preferences—inconsistency, imprecision, and other domains
Y Zhang, PA Coello, GH Guyatt, JJ Yepes-Nuñez, EA Akl, G Hazlewood, ...
Journal of clinical epidemiology 111, 83-93, 2019
1802019
Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate?
EM Pullenayegum, JE Tarride, F Xie, R Goeree, HC Gerstein, D O'Reilly
Value in Health 13 (4), 487-494, 2010
1632010
Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units
BC Johnston, K Thorlund, HJ Schünemann, F Xie, MH Murad, VM Montori, ...
Health and quality of life outcomes 8, 1-5, 2010
1592010
Validation of Chinese Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in patients scheduled for total knee replacement
F Xie, SC Li, R Goeree, JE Tarride, D O’Reilly, NN Lo, SJ Yeo, KY Yang, ...
Quality of Life Research 17, 595-601, 2008
1362008
Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application
R Goeree, J He, D O’Reilly, JE Tarride, F Xie, M Lim, N Burke
ClinicoEconomics and Outcomes Research, 89-104, 2011
1282011
The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women
R Hopkins, R Goeree, E Pullenayegum, J Adachi, A Papaioannou, F Xie, ...
BMC musculoskeletal disorders 12 (1), 209, 2011
1262011
Evaluating progression-free survival as a surrogate outcome for health-related quality of life in oncology: a systematic review and quantitative analysis
B Kovic, X Jin, SA Kennedy, M Hylands, M Pędziwiatr, A Kuriyama, ...
JAMA Internal Medicine 178 (12), 1586-1596, 2018
1232018
Cross-cultural adaptation and validation of Singapore English and Chinese versions of the Knee injury and Osteoarthritis Outcome Score (KOOS) in Asians with knee osteoarthritis …
F Xie, SC Li, EM Roos, KY Fong, NN Lo, SJ Yeo, KY Yang, W Yeo, ...
Osteoarthritis and cartilage 14 (11), 1098-1103, 2006
1192006
Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist
F Xie, K Gaebel, K Perampaladas, B Doble, E Pullenayegum
Medical Decision Making 34 (1), 8-20, 2014
1042014
Be healthy in pregnancy: exploring factors that impact pregnant women's nutrition and exercise behaviours
LN Grenier, SA Atkinson, MF Mottola, O Wahoush, L Thabane, F Xie, ...
Maternal & child nutrition 17 (1), e13068, 2021
1032021
Discussing study limitations in reports of biomedical studies-the need for more transparency
MA Puhan, EA Akl, D Bryant, F Xie, G Apolone, G Riet
Health and quality of life outcomes 10, 1-4, 2012
1032012
The European organization for research and treatment of cancer quality of life questionnaire (EORTC QLQ-C30): validation of English version in Singapore
N Luo, CSL Fones, SE Lim, F Xie, J Thumboo, SC Li
Quality of Life Research 14, 1181-1186, 2005
992005
GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence—An overview in the context of health decision-making
JL Brozek, C Canelo-Aybar, EA Akl, JM Bowen, J Bucher, WA Chiu, ...
Journal of clinical epidemiology 129, 138-150, 2021
942021
Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: a systematic literature review and meta-analysis
MJ Zoratti, A Siddiqua, RE Morassut, D Zeraatkar, R Chou, J van Holten, ...
EClinicalMedicine 18, 2020
932020
The system can't perform the operation now. Try again later.
Articles 1–20